De Novo COL7A1 mutation in a patient with trisomy 21: coexistence of dystrophic epidermolysis bullosa and Down syndrome

2012 ◽  
Vol 51 (9) ◽  
pp. 1078-1081
Author(s):  
Javiera A. Catalán ◽  
Fernando A. Rodríguez ◽  
María J. Yubero ◽  
Francis Palisson ◽  
María J. Gana ◽  
...  
2002 ◽  
Vol 27 (1) ◽  
pp. 56-58 ◽  
Author(s):  
S. Matsuba ◽  
Y. Suga ◽  
N. Mayuzumi ◽  
S. Ikeda ◽  
H. Ogawa

Dermatology ◽  
2011 ◽  
Vol 223 (3) ◽  
pp. 219-221 ◽  
Author(s):  
N. Cuadrado-Corrales ◽  
C. Sánchez-Jimeno ◽  
M. García ◽  
C. Ayuso ◽  
R. De Lucas ◽  
...  

2014 ◽  
Vol 134 (4) ◽  
pp. 1138-1140 ◽  
Author(s):  
David T. Woodley ◽  
Jon Cogan ◽  
Xinyi Wang ◽  
Yingping Hou ◽  
Cyrus Haghighian ◽  
...  

Author(s):  
R. J McKinlay Gardner ◽  
David J Amor

This chapter reviews the archetypical chromosome disorder, namely Down syndrome (DS; trisomy 21), and the various different chromosomal forms that may be the basis of it: standard trisomy 21, translocation trisomy, both de novo and inherited, and other rare forms. The concept of dosage imbalance as the basis of the pathogenesis is reviewed, and the “DS critical region” on chromosome 21 is examined. Reproductive risks associated with each of these DS types are discussed. The chapter considers the other full autosomal trisomies, T13 and T18, and also (mosaic) T9. Triploidy, as the basis of hydatidiform mole, is reviewed. Also reviewed are the influence of parental, mostly maternal, age, in the genesis of these aneuploidies, and the effect of secular change on these observations. Tables provide precise age-related risk figures for recurrence risk of T21 and more general figures for other trisomies.


1984 ◽  
Vol 51 (3) ◽  
pp. 363-366 ◽  
Author(s):  
D. S. Krishna Murthy ◽  
Sabita Roy ◽  
P. M. Contractor ◽  
V. C. Shah

Sign in / Sign up

Export Citation Format

Share Document